Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy

SIMPLE SUMMARY: We developed a novel risk-scoring model for hepatocellular carcinoma development in treatment-naïve patients with chronic hepatitis B virus infection who are starting antiviral therapy with entecavir or tenofovir. The model reflects age, platelet count, hepatitis B e antigen positivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jae Seung, Lee, Hyun Woong, Lim, Tae Seop, Shin, Hye Jung, Lee, Hye Won, Kim, Seung Up, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Kim, Beom Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656676/
https://www.ncbi.nlm.nih.gov/pubmed/34885000
http://dx.doi.org/10.3390/cancers13235892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656676/
https://www.ncbi.nlm.nih.gov/pubmed/34885000
http://dx.doi.org/10.3390/cancers13235892

Ejemplares similares